US OptionsDetailed Quotes
LUNR241213P10000
- 0.01
- -0.01-50.00%
15min DelayClose Dec 13 16:00 ET
0.01High0.01Low
0.01Open0.02Pre Close1 Volume148 Open Interest10.00Strike Price1.00Turnover7939.80%IV14.51%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0265Delta0.0636Gamma1168.50Leverage Ratio-70.0615Theta0.0000Rho-30.94Eff Leverage0.0000Vega
Intuitive Machines Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
7
1
1
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...
+2
1
$Intuitive Machines (LUNR.US)$ what is the next milestone?
1
$Intuitive Machines (LUNR.US)$
Why is this stock volume so low 😆 i have a good insight for their future potential tho
Why is this stock volume so low 😆 i have a good insight for their future potential tho
1
11
$Intuitive Machines (LUNR.US)$
guaranteed to trade 300% higher come successful landing.
GUARANTEED.
FREE not financial advice
guaranteed to trade 300% higher come successful landing.
GUARANTEED.
FREE not financial advice
2
2
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.